Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 136 Pharmacy PhD Research Projects PhD Projects, Programmes & Scholarships
Pharmacy PhD Research Projects PhD Projects, Programmes & Scholarships
We have 136 Pharmacy PhD Research Projects PhD Projects, Programmes & Scholarships
A PhD in Pharmacy gives you the chance to lead your own research project that will further our current understanding of pharmaceuticals. Whether you are researching medicines tailored to an ageing population, optimising existing drugs through changes in dosage, or looking at the causes of neurological and psychiatric diseases, you will be aiming to improve the lives of millions of people around the globe.
What’s it like to study a PhD in Pharmacy?
Doing a PhD in Pharmacy, you will become proficient in the skills necessary to contribute to a research portfolio which spans pharmacy practice, pharmaceutics, and drug discovery. You will spend time reading around your research area and gain inspiration for methods to improve your experimental work. Your main aim will be to exploit the current advances in pharmaceutical practices and biological sciences.
Some typical research topics in Pharmacy include:
- nanomedicine and biotherapeutics
- developing nanomaterials for drug delivery
- infection and antimicrobial resistance
- pharmacy practice
Typical Pharmacy PhD research projects take between three and four years to complete. During a standard PhD day, you will either be in the laboratory performing, preparing, or planning experiments, (if your project is laboratory based), researching pharmacy practice and policy, writing up sections of your thesis, and chatting to your colleagues and supervisor about your current and upcoming work.
To be awarded your PhD, you must submit a thesis of about 60,000 words and defend this during your viva exam.
PhD in Pharmacy entry requirements
The entry requirements for a typical PhD in Pharmacy usually involves a Bachelors and a Masters degree in a related subject. You will also need to submit a compelling research proposal detailing your study plans. You may also need some professional experience in Pharmacy, depending on the programme.
PhD in Pharmacy funding options
In the UK, PhDs in Pharmacy are funded by the Medical Research Council (MRC), which provides a tuition fee waiver and a living cost stipend. Depending on the programme, you may submit your own research proposal before being considered for funding or apply for a project that already has funding attached.
It is also possible to apply for a PhD loan to help with the costs of a doctorate in Pharmacy (although this cannot be combined with Research Council funding). Other options for financial support include university scholarships, graduate teaching assistantships and charities.
If you are considering a part-time PhD in Pharmacy, it may also be worth asking your employer if they are happy to sponsor you.
PhD in Pharmacy careers
On completion of your PhD, you may go into a research role at a university or pharmaceutical company, or you may find a career in regulatory affairs, the NHS (National Health Service) or scientific publishing, drug licensing or clinical trial research.
PhD saved successfully
Relationship between antibiotic therapy and development of antimicrobial resistance in patients with bronchiectasis and COPD
To decrease the risk of acute infective exacerbations or flare-ups of their condition, individuals with bronchiectasis and COPD are frequently prescribed long-term oral and inhaled antibiotics. Read more
Production of super small nanocrystals for drug delivery to target tissues
The student will be involved in an exciting project related to the design, formulation and in vitro/in vivo characterisation of super small drug nanocrystals with specific surface properties to enhance drug accumulation in target tissues, such as the lymphatic or central nervous systems. Read more
Prescribing, medicine access and medicines use in community-based palliative care
Community medical and nursing teams are increasingly called upon to deliver palliative and end-of-life care to terminally ill people living in their own homes and in long-term care settings such as nursing homes. Patients and carers may experience problems in medicines access, and processes can be lengthy and burdensome. Read more
Polymer-engineering nanocages for protein delivery
Protein therapeutics are a fast-acting and potent class of medicine with remarkable success in the treatment of several relevant disorders. Read more
Peptide-based nanoparticles for brain targeted gene delivery
Gene therapy has the potential to provide therapeutic benefit to millions of people with neurodegenerative diseases and cancer. Delivery into the brain is hampered by the blood-brain barrier (BBB), which limits the efficacy of both conventional and novel therapies at the target site. Read more
Multifunctional Biomaterials to Combat Infection and Modulate Inflammation
Implantable medical devices are commonplace in modern medicine (e.g. joint replacements, stents, artificial heart valves, etc.), and are of ever increasing interest in the field of regenerative medicine. Read more
Microneedle delivery systems for next-generation antibody therapeutics
Microneedle arrays are minimally-invasive devices that painlessly, and without drawing blood, penetrate the skin’s stratum corneum barrier. Read more
Microfluidic technologies for the production of Nanomedicines
Progress in drug design has led to the development of new molecules. However, the limited ability to selectively deliver these molecules at well-defined dosing regimens remains a significant challenge. Read more
Mechanochemical synthesis of polymer-drug conjugates via reactive extrusion
Polymer–drug conjugate (PDCs) therapeutics are pharmacologically active macromolecular constructs comprising at least one therapeutic agent covalently bound to a polymeric carrier. Read more
Measurement of outcomes for medicines management interventions for people living with dementia in primary care
Medicines management is a complex process for people living with dementia (PLWD), who often have other comorbidities and are frequently prescribed multiple regular medicines. Read more
Investigating the role of USP17 in EMT
USP17 is over-expressed in a range of primary tumours (NSCLC, breast, colorectal, cervical, ovarian, osteosarcoma) and its depletion blocks the growth, and migration, of cells from all of these cancer types. Read more
Investigating the role of the microbiome in infection and health outcomes following renal transplantation
Many infections and disease states are closely linked to associated microbiomes, either of the patient themselves or the surrounding clinical environment. Read more
Investigating the clinical and molecular significance of the microbiome in breast cancer
Breast Cancer (BC) is the most common cancer in the UK, accounting for 15% of new cancer cases. There is a significant unmet clinical need to understand why some cancers do not respond to treatment and what drives metastasis. Read more
High throughput screening models for intracellular delivery of antimicrobial nanotherapeutics
Fungal and bacterial infections contribute to over 7 million deaths yearly, affecting over 300 million people globally (. GAFFI. ). Read more
Enzyme-responsive peptide hydrogel as in situ forming long-acting drug delivery implants
One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more